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Abstract
Background/Objective:  The  purpose  of  this  study  was  to  assess  psychometric  properties  of  the
Brief Symptom  Inventory  (BSI-18),  evaluate  the  measurement  invariance  with  respect  to  sex,
age, and  tumor  location,  and  to  analyze  associations  between  social  support  and  sociodemo-
graphic and  clinical  variables  among  individuals  with  resected,  non-advanced  cancer.
Method:  A  conﬁrmatory  factor  analysis  was  conducted  to  explore  the  dimensionality  of  the
scale and  test  invariance  across  sex,  age,  and  tumor  localization  in  a  prospective,  multicenter
cohort of  877  patients  who  completed  the  BSI-18  and  Multidimensional  Scale  of  Perceived  Social
Support (MSPSS).
Results:  The  results  show  that  3-factor  and  1-factor  measurement  models  provided  a  good
ﬁt to  the  data;  however,  a  three-factor,  second-order  model  was  deemed  more  appropriate
and parsimonious  in  this  population.  Alpha  coefﬁcients  ranged  between  .75  and  .88.  Test  of
measurement  invariance  showed  strong  invariance  results  for  sex,  age,  and  tumor  location;
strong invariance  over  time  was  likewise  assumed.  Less  perceived  social  support  appears  to
correlate  with  all  BSI  factors.
Conclusions:  The  study  conﬁrmed  the  tridimensional  structure  of  the  BSI-18  and  invariance
across age,  sex,  and  tumor  localization.  We  recommend  using  this  instrument  to  measure
anxiety, depression,  and  somatization  in  epidemiological  research  and  clinical  practice.
© 2019  Asociacio´n  Espan˜ola  de  Psicolog´ıa  Conductual.  Published  by  Elsevier  Espan˜a,  S.L.U.  This
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Estructura  factorial  e  invarianza  de  medida  del  Brief  Symptom  Inventory  (BSI-18)  en
pacientes  con  cáncer
Resumen
Antecedentes/Objetivo:  El  propósito  de  este  estudio  fue  evaluar  las  propiedades  psicométricas
del Brief  Symptom  Inventory  (BSI-18),  la  invariancia  con  respecto  al  sexo,  edad  y  localización
del tumor,  y  analizar  la  asociación  con  el  apoyo  social  y  variables  sociodemográﬁcas  y  clínicas.
Método: Se  realizó  un  análisis  factorial  conﬁrmatorio  para  explorar  la  dimensionalidad  y  se
analizó la  invarianza  en  función  del  sexo,  edad  y  localización  del  tumor  en  una  muestra  prospec-
tiva y  multicéntrica  de  877  pacientes  que  completaron  el  BSI-18  y  la  Multidimensional  Scale  of
Perceived Social  Support  (MSPSS).
Resultados:  Tanto  el  modelo  unifactorial  como  el  trifactorial  proporcionaron  un  buen  ajuste  a
los datos;  sin  embargo,  un  modelo  de  segundo  orden  de  tres  factores  se  consideró  más  apropiado
en esta  población.  Los  coeﬁcientes  alfa  oscilaron  entre  0,75  y  0,88.  Se  halló  una  invarianza
fuerte para  sexo,  edad  y  localización  del  tumor,  y  una  fuerte  invarianza  en  el  tiempo.  El  apoyo
social percibido  se  correlacionó  negativamente  con  todos  los  factores  BSI.
Conclusiones:  El  estudio  conﬁrma  la  estructura  tridimensional  del  BSI-18  y  la  invarianza  en  sexo,
edad y  localización  del  tumor.  El  instrumento  puede  recomendarse  para  evaluar  la  ansiedad,
depresión y  somatización  en  investigación  epidemiológica  y  en  la  práctica  clínica.
© 2019  Asociacio´n  Espan˜ola  de  Psicolog´ıa  Conductual.  Publicado  por  Elsevier  Espan˜a,  S.L.U.
Este es  un  art´ıculo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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&The  diagnosis  of  cancer  and  multimodal  therapy  have
een  associated  with  increased  risk  of  psychological  distress
nd  mental  comorbidity  (Bao  et  al.,  2019;  Jimenez-Fonseca
t  al.,  2018).  Approximately  half  of  the  oncology  patients
ho  initiate  treatment  with  chemotherapy  present  anxiety
nd  more  than  one-third  display  depression  (Jimenez-
onseca  et  al.,  2018).  Despite  this,  less  than  10%  of  these
eople  receive  psychosocial  treatment  (Calderon  et  al.,
018).  The  failure  to  detect  and  treat  high  levels  of  psycho-
ogical  distress  have  been  associated  with  lower  adherence
o  treatment  recommendations,  less  satisfaction  with  the
are  received,  and  worse  quality  of  life  (Kuba  et  al.,  2019;
hin  et  al.,  2017).
The  Brief  Symptom  Inventory-18  (BSI-18)  is  one  of  the
ost  widely  used  scales  to  appraise  psychological  distress
Derogatis,  2001).  The  BSI-18  is  the  shortest  and  most
ecent  of  the  scales  designed  by  Derogatis;  its  predecessors
re  the  Symptom  Checklist-90-Revised  (SCL-90-R;  90  ítems;
erogatis,  1994)  and  the  Brief  Symptom  Inventory  (BSI;  53
tems;  Derogatis,  1993).  The  SCL-90-R  and  BSI  contemplate
ine  dimensions  of  psychological  distress  versus  the  BSI-18
hat  explores  three  dimensions  (6  items  each)  ----  Somatiza-
ion,  Depression,  and  Anxiety  (Derogatis,  2001).  According
o  Derogatis  (2001),  the  BSI-18  has  two  main  advantages
ver  its  predecessors:  one  is  its  brevity  and  is  easy  both  to
dminister  and  to  correct.  Secondly,  it  has  three  symptom
imensions  that  are  conceptual  and  empirically  highly  homo-
eneous;  each  one  correlates  closely  with  the  sum  total  of  all
he  items  that  constitute  psychological  distress  (Abraham,
ruber-Baldini,  Harrington,  &  Shulman,  2017;  Galdón  et  al.,
008;  Lancaster,  McCrea,  &  Nelson,  2016).Originally,  the  BSI-18  factorial  structure  was  evaluated
y  means  of  a  principal  component  analysis  (PCA)  based
n  a  sample  of  1,134  American  workers  (Derogatis,  2001).
2
u
ehe  PCA  has  exhibited  a  second-order  factorial  structure
hereby  the  items  on  the  questionnaire  are  weighed  in  three
ifferent  factors:  somatization,  anxiety,  and  depression.
he  sum  of  all  the  items  are  weighted  in  a  general  factor
f  psychological  distress  (Derogatis,  2001).  Several  studies
f  the  BSI-18  have  validated  its  original  three-dimensional
tructure  design  (Meijer,  de  Vries,  &  van  Bruggen,  2011;
ecklitis,  Blackmon,  &  Chang,  2017;  Wang  et  al.,  2010;
iesner  et  al.,  2010).  However,  other  authors  have  put
orth  an  alternative  4-factor  model  (depression,  somatiza-
ion,  agitation,  and  panic)  (Andreu  et  al.,  2008),  as  well  as  a
-factor  model,  consisting  of  the  original  three  dimensions
lus  suicidal  ideation  (Zabora  et  al.,  2001).  Despite  this,  sup-
ort  for  this  latter  four  factor  model  is  weak,  especially  for
uicidal  ideation,  given  that  it  is  based  on  a  single  item;  the
hree  factor  model  is  therefore  preferable  (Recklitis  et  al.,
017).  Finally,  there  are  authors  that  have  suggested  that
he  BSI-18  examines  a  single  dimension  of  general  psycho-
ogical  distress  (Meijer  et  al.,  2011;  Torres,  Miller,  &  Moore,
013).
Recently,  the  study  of  the  scale’s  factorial  invariance  has
pawned  interest,  as  it  is  important  to  be  able  to  validly
ompare  results  from  different  individuals  in  clinical  assess-
ent,  and  across  different  groups  (i.e.,  sex,  age,  or  tumor).
esting  the  hypothesis  of  invariance  enables  intergroup  com-
arisons  to  be  made,  yielding  more  easily  interpretable
utcomes  versus  those  scenarios  in  which  this  premise  is  no
xamined.  Thus  far,  only  a  handful  of  studies  have  looked  at
he  matter  of  invariance  based  on  certain  variables  such  as
ex  and  age  (Li  et  al.,  2018;  von  Brachel,  Bieda,  Margraf,
 Hirschfeld,  2018;  Wang  et  al.,  2010;  Wiesner  et  al.,
010),  but  not  according  to  the  tumor.  Wiesner  et  al.  (2010)
sed  a  mean  and  covariance  structures  (MACS)  analysis  to
xamine  the  BSI-18  in  a  sample  of  4,711  mothers  of  ﬁfth
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DFactor  structure  and  measurement  invariance  of  the  Brief  S
grade  students.  The  authors  concluded  that  among  Latin
women,  the  unifactorial  solution  was  superior  to  the  orig-
inally  designed  three-factor  structure.  Wang  et  al.  (2010)
investigated  invariance  in  a  study  of  Chinese  adult  drug
users,  and  support  the  three-factor,  second-order  model
over  the  unifactorial  model,  and  indicate  that  the  BSI-18’s
factorial  and  metric  structure  is  constant  in  all  the  study
populations.  Li  et  al.  (2018)  evaluated  the  factorial  invari-
ance  of  the  BSI-18  in  Chines  sample,  and  concluded  that
the  bifactorial  model  (somatization  and  depression)  ﬁt  the
data  better  and  that  it  was  also  equivalent  in  both  sexs.  von
Brachel  et  al.  (2018)  analyzed  the  longitudinal  invariance  of
the  BSI-18  in  1,081  patients  undergoing  psychotherapy,  and
concluded  that  the  BSI-18  is  better  conceptualized  as  a four
dimensional  that  exhibits  a  strict  invariance  of  longitudinal.
In  short,  the  study  of  the  factorial  structure  and  invari-
ance  of  the  BSI-18  yields  disparate  results  and,  to  the  best  of
our  knowledge,  no  invariance  studies  have  been  conducted
based  on  sex,  age,  and  tumor  type  in  a  large  sample  of
individuals  with  cancer.  Therefore,  the  two  initial  objec-
tives  of  the  instrumental  study  (Carretero-Dios  &  Pérez,
2007;  Ramos-Álvarez,  Moreno-Fernández,  Valdés-Conroy,  &
Catena,  2008)  were:  (1)  to  evaluate  the  factorial  structure
and  psychometric  properties  of  the  BSI-18  in  our  popula-
tion  (cancer  patients)  and  (2)  to  assess  the  measurement
invariance  of  BSI-18  scores  in  groups  deﬁned  by  sex,  age,
and  tumor  site.  Additionally,  we  appraised  (3)  the  con-
struct  validity  of  the  scores  and  (4)  their  sensitivity  to
treatment-induced  change  among  subjects  with  resected,
non-advanced  cancer.
Method
Participants
Socio-demographic  and  clinical  characteristics  are  pre-
sented  in  Table  1.  The  sample  comprised  877  patients  with
a  mean  age  of  36  years  (SD  =  13.4,  range  25-84);  59.7%
the  participants  were  female.  Most  were  married  or  part-
nered  (75.8%)  and  had  a  primary  level  of  education  (66.4%).
As  for  place  of  residence,  40.5%  of  the  participants  live  in
a  large  city  (>100,000  inhabitants);  26.6%,  in  a  medium-
sized  city  (10,000-100,000),  and  32.8%,  in  a  small-sized  city
(<10,000).  As  for  clinical  characteristics,  the  most  frequent
cancer  types  were  colon  (47.4%)  and  breast  (31.4%),  stage
I-II  (55.4%).
Thirty-one  physicians  participated  in  this  study;  80.6%
(n  =  25)  were  female;  mean  age  was  36.8  years  (SD  =  8.3,
range  28-62  years),  with  12.7  years  of  experience  (SD  =  8.1,
range  4-37  years).  No  signiﬁcant  differences  were  detected
between  male  and  female  oncologists  with  respect  to  age  (t
=  0.32,  p  =  .749)  or  years  of  experience  (t  =  0.31,  p  =  .756).
Most  were  super-specialists  (71%)  and  worked  at  a  public
center.
InstrumentsBrief  Symptom  Inventory  (BSI-18;  Derogatis,  2001)  includes
18  items  divides  into  three  dimensions  (Somatization,
Depression,  and  Anxiety)  and  the  total  score,  the  Global
Severity  Index  (GSI)  to  assess  general  psychological  distress
D
s
oom  Inventory  (BSI-18)  in  cancer  patients  73
n  clinical  and  community  populations  (Appendix  1).  Respon-
ents  were  asked  to  answer  in  relation  to  how  they  had  felt
ver  the  last  7  days  and  each  item  was  rated  on  a  5-point
ikert  scale  from  0 (not  at  all)  to  4  (extremely). Raw  scores
re  converted  to  standardized  T  scores  which  are  charac-
erized  by  a distribution  with  a  mean  of  50  and  standard
eviation  (SD)  of  10.  According  to  the  cutoff  recommended
y  Derogatis  (2001), a  T-score  ≥63  was  used  as  indicative  of
aseness.  In  this  study,  Cronbach’s  alpha  was  .75-.88.
Multidimensional  Scale  of  Perceived  Social  Support
MSPSS;  Zimet,  Powell,  Farley,  Werkman,  &  Berkoff,  1990)
s  a  12-item,  self-report  scale  that  measures  perceptions
nd  adequacy  of  social  support  from  three  sources:  fam-
ly,  friends,  and  signiﬁcant  others.  The  total  score  reﬂected
he  total  degree  of  social  support  that  individuals  received.
tems  are  scored  on  a  7-point  Likert  scale  and  total  scores
ange  from  7  to  84,  with  higher  scores  indicating  greater
erceived  support.  In  this  study,  Cronbach’s  alpha  for  the
cale  was  .89.
Demographic  survey.  The  following  data  were  obtained:
ge,  sex,  marital  status,  educational  level,  occupational
eld,  tumor  site,  stage,  and  treatment.  The  oncologist-
elated  variables  were  sex,  age,  years  of  experience,  type
f  medical  oncologist  (generalist  vs.  specialized),  and  type
f  hospital  (academic  vs.  non-academic).
rocedure
EOcoping  is  a  national,  multicenter,  cross-sectional,
rospective  study  of  the  Continuous  Care  Group  of  the  Span-
sh  Society  of  Medical  Oncology  (SEOM)  conducted  between
uly  2015  and  February  2019  in  15  Medical  Oncology  depart-
ents  in  Spain,  from  10  autonomous  communities.  The
rotocol  was  approved  by  the  Ethics  Committee  of  each
ospital  and  by  the  Spanish  Agency  for  Medicines  and  Medi-
al  Devices  (AEMPS)  and  all  participants  signed  informed
onsent  forms  prior  to  inclusion.  The  study  consists  of  self-
eport  scales  that  the  patients  completed  at  the  beginning
nd  end  of  adjuvant  treatment.  Each  questionnaire  con-
ained  written  instructions  and  speciﬁed  that  completion
as  voluntary  and  anonymous.  Patients  completed  all  pre-
reatment  questionnaires  during  the  week  following  their
rst  visit  to  the  Medical  Oncology  Department  to  decide  on
djuvant  treatment.
The  population  consisted  of  consecutive  patients  with
istologically  conﬁrmed,  non-advanced,  surgically-treated
reast  and  colorectal  cancer  for  which  international  clinical
uidelines  considered  adjuvant  treatment  to  be  an  option.
atients  were  excluded  if  they  were  under  18  years  of  age,
ad  been  treated  with  preoperative  radio-or  chemotherapy,
nly  hormone  therapy,  or  adjuvant  radiotherapy  without
hemotherapy,  and  if  they  had  any  serious  mental  illness
hat  prevented  them  from  understanding  the  study.  We
creened  1,003  patients;  877  were  eligible  for  this  analysis
nd  126  were  excluded.
ata  analysisata  analyses  were  conducted  in  ﬁve  stages.  In  the  ﬁrst
tage,  basic  sample  and  item  descriptive  statistics  were
btained.  In  the  second  stage,  the  dimensionality  of  the
74  C.  Calderon  et  al.
Table  1  Sample  demographic  and  clinical  characteristics  (N  =  877).
Characteristics  Category  Frequency  Percentage
Sex  Male  353  40.3
Female 524  59.7
Marital status  Married  or  partnered  665  75.8
Single, widow  or  divorced  211  24.2
Age <55  318  36.3
56-65 258  29.4
>65 301  34.3
Education background ≤  High  school 580  66.4
(missing: 4) College  and  above 293  33.6
Employment  status  Inactive  527  60.1
Active 350  39.9
Tumor site  Colon  416  47.4
Breast 275  31.4
Others 186  21.2
Tumor stage I-II  466  55.4
III 375  42.8
Unknown  36  4.1
Tumor treatment  Chemotherapy  591  67.4
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SI-18  item  scores  was  assessed  using  exploratory  fac-
or  analyses  (EFAs)  and  a  multifaceted  approach  (detailed
elow).  Given  that  a  clear,  interpretable  solution  was
ttained  at  this  stage,  multiple-group  conﬁrmatory  factor
nalyses  (CFAs)  were  then  performed  and  factorial  invari-
nce  was  assessed  in  groups  determined  by  sex,  age,  and
umor  site.  In  the  fourth  stage,  validity  relations  were
ppraised  via  (a)  product-moment  correlations  between  BSI-
8  raw  scale  scores  and  MPSSS  scores  (practical  validity)
nd  (b)  a  structural  equation  model,  in  which  the  CFA
as  extended  to  include  MPSS  scores  (theoretical  validity).
inally,  mean  pre-/post-treatment  changes  were  assessed
y  means  of  a  two-wave  structural  model.
Descriptive  statistics  at  the  ﬁrst  stage  were  obtained  with
he  SPSS  v23.  Second  stage  EFAs  were  performed  with  the
ACTOR  program  (Ferrando  &  Lorenzo-Seva,  2017;  Lorenzo-
eva  &  Ferrando,  2013)  and  dimensionality  was  assessed
ith  (a)  conventional  goodness-of-ﬁt  indices;  (b)  measures
f  appropriateness  and  essential  unidimensionality,  and  (c)
dded-value  analyses.  The  estimation  procedure  for  all
FAs  was  robust,  unweighted  least  squares  with  second-
rder  (mean  and  variance)  corrections  (ULS-MV).  The  indices
elected  in  were  (a)  the  Standardized  root-mean-square
esidual  (SRMS)  and  the  root-mean-square  error  of  approx-
mation  (RMSEA),  as  measures  of  relative  ﬁt,  and  the  CFI
ndex  as  a  measure  of  comparative  ﬁt  with  respect  to  the
ull  independence  model.  Measures  in  (b)  consisted  of:  the
 index,  which  assesses  the  strength  and  replicability  of
he  solution;  the  explained  common  variance  (ECV)  index,
hich  determines  closeness  to  unidimensionality,  optimal
mplementation  of  parallel  analysis  (PA)  (Timmerman  &
orenzo-Seva,  2011),  and  Schwarz’s  Bayesian  Information
riterion  (BIC).  Finally,  added-value  analyses  (Ferrando  &
orenzo-Seva,  2019)  assess  the  extent  to  which  scores  on  a
iven  factor  are  better  predicted  from  the  score  estimates
o
y 286  32.6
ased  on  this  factor  than  from  the  score  estimates  based  on
he  overall  single  factor.
Multiple  group  CFAs  were  ﬁtted  using  robust,  weighted
east  squares  estimation  with  second-order  (mean  and
ariance)  corrections  (WLS-MV),  as  implemented  in  Mplus
Muthén  &  Muthén,  2012).  Model  ﬁt  and  appropriateness
ere  explored  with  RMSEA  and  CFI.  As  for  reference  val-
es,  CFI  values  ≥.95  are  indicative  of  good  model  ﬁt
Schermelleh-Engel,  Moosbrugger,  &  Müller,  2003),  whereas
MSEA  values  ≤.06  indicate  a satisfactory  ﬁt  (Hair,  Black,  &
abin,  2010).
The  property  of  measurement  invariance  (MI)  appraised
t  this  stage  indicates  that  the  BSI  items  measure  the  same
imensions  with  the  same  structure  in  all  the  groups  to  be
ompared.  This  property  is  a  prerequisite  if  BSI  scores  are  to
e  validly  interpreted  and  compared.  Various  MI  levels  can
e  obtained;  likewise,  there  is  considerable  debate  regard-
ng  the  appropriate  level  for  a  clinical  instrument  such  as  the
SI.  Our  position  is  that  strong  invariance  is  an  attainable
oal  that,  if  achieved,  sufﬁced  to  establish  valid  compar-
sons  both  at  the  individual  and  at  the  mean-group  level
Millsap  &  Meredith,  2007).  Therefore,  provided  that  strong
nvariance  is  obtained,  the  mean  differences  sex-,  age-,  and
umor  site-deﬁned  groups  were  assessed  at  this  third,  CFA
tage.
The  CFA  model  of  stage  3,  extended  so  as  to  include
he  MPSS  scores  as  external  variables,  was  the  structural
odel  used  to  evaluated  validity  relations  at  the  fourth
tage.  The  model  was  ﬁtted  and  model-data  ﬁt  was  gauged
sing  the  same  procedures  detailed  above  for  the  third-
tage  analyses.  Finally,  the  two-wave  model  to  appraise
ensitivity  to  post-treatment  change  was  strongly-invariant
ver  time;  likewise,  it  was  ﬁtted  and  assessed  by  means
f  the  same  procedures  described  in  the  third-stage  anal-
ses.
Factor  structure  and  measurement  invariance  of  the  Brief  Sympt
Table  2  Summary  Statistics  for  the  BSI-18  items  by  sub-
scale,  and  skewness.
Item  Item  number  M  SD  Skews
Depression  subscale  (˛  =  .83)
No  interest  2  0.67  1.04  2.48
Lonely 5  0.46  0.93  2.32
Blue 8  1.17  1.21  1.55
Worthlessness  11  0.50  0.93  2.93
Hopelessness  14  0.59  0.97  1.17
Suicide  17  0.09  0.44  2.04
Anxiety  subscale  (˛  =  .89)
Nervousness  3  1.54  1.32  3.20
Tense 6  1.12  1.19  2.21
Scared 9  0.42  0.86  1.14
Panic 12  0.41  0.92  1.40
Restlessness  15  0.50  0.95  0.88
Fearful  18  0.96  1.16  2.04
Somatic  subscale  (  =  .72)
Faintness  1  0.33  0.74  0.41
Chest paints  4  0.26  0.70  5.51
Nausea  7  0.76  1.13  0.89
Short breath  10  0.30  0.74  1.30
Numbness  13  0.71  1.06  1.81
Weakness  16  0.88  1.10  2.40
GSI total  (˛  =  .91)
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tency  in  the  procedures,  all  the  structural  models  that  followNote. BSI-18 = Brief symptom Inventory-18; GSI = Global Severity
Index. All correlations were signiﬁcant at p < .05.
Results
Descriptive  statistics  for  BSI  items
Descriptive  statistics  of  the  eighteen  BSI  items  can  be  found
in  Table  2.  Mean  item  scores  ranged  from  0.09  (item  17)  to
1.54  (item  3).  BSI-18  item  score  distributions  were  unimodal
and  asymmetrical  (positively  skewed),  thereby  indicating
that  most  of  the  values  were  concentrated  at  the  lowest
end  of  the  response  scale.  Cronbach’s  alpha  estimates  for
raw  test  scores  ranged  from  .75  to  .88,  which  are  similar
to  those  reported  in  a  community  cancer  sample  (Galdón
et  al.,  2008;  Recklitis  et  al.,  2017)  that  varied  from  .75  to
.88  in  adult  survivors  of  childhood  cancer  (Recklitis  et  al.,
2017)  and  .62-.70  in  a  Spanish  breast  cancer  sample  (Galdón
et  al.,  2008).
BSI-18  dimensionality  assessment  with  EFA’s
Taking  into  account  the  descriptive  results  summarized
above  (skewed  item  scores),  as  well  as  the  fact  that
the  test  is  not  very  long  and  the  sample  is  reasonably
large,  the  best  model  choice  to  ﬁt  the  data  is  nonlinear
underlying-variables-approach  FA  (UVA-FA  e.g.  [Muthén  &
Muthén,  2004]).  In  this  modeling,  the  item  scores  are  treated
as  ordered-categorical  variables  and  the  EFA  is  ﬁtted  to
the  inter-item  polychoric  correlation  matrix  (Ferrando  &
Lorenzo-Seva,  2014).  As  preliminary  analyses,  sampling  ade-
quacy  was  assessed  by  the  KMO  and  Bartlett’s  sphericity  test
and  was  considered  to  be  very  good.
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In  accordance  with  previous  studies,  models  containing
etween  1  and  3  factors  were  ﬁtted  to  the  data.  The  4-
actor  solution  was  not  attempted  because  the  ﬁt  of  the
-factor  model  was  too  good.  Double  cross-validations  based
n  random,  fully  independent  sub-samples  were  made  for
he  EFA  solutions,  and  the  across-samples  results  were  vir-
ually  identical  in  all  cases  (coefﬁcients  of  congruence  were
lways  above  .96).  So,  only  the  results  based  on  the  entire
ample  are  reported.  Results  for  the  unidimensional  and  the
-factor  solution  are  located  in  the  upper  panel  of  Table  3.
As  a  summary,  the  unidimensional  model  has  only  a
arginally  acceptable  ﬁt  in  pure  goodness-of-ﬁt  terms,
hereas  the  ﬁt  of  the  3-factor  model  is  excellent  by  all  the
tandards.  However,  the  ECV  value  suggests  that  there  is  a
trong  dominant  factor  running  through  all  the  18  items,  and
he  PA-based  procedure  indicates  the  unidimensional  solu-
ion  as  the  most  replicable.  In  contrast,  the  BIC  results  point
o  the  3-factor  solution  as  being  preferable.
To  obtain  further  information  in  order  to  decide  which
imensionality  was  most  appropriate,  the  solution  in  three
actors  was  next  rotated  to  achieve  maximum  factor  sim-
licity  by  using  the  Promin  criterion  (Lorenzo-Seva,  1999).
he  rotated  pattern  closely  approached  a  simple  structure
Bentler’s  simplicity  index  was  .98)  and  allocated  all  the
tems  in  the  ‘a  priori’ expected  structure.  Only  two  items:  8
feeling  blue)  and  14  (hopelessness  about  the  future)  were
ound  to  be  factorially  complex  and  loaded  on  both  the
epression  and  anxiety  factors.
The  lower  panel  of  Table  3  displays  further  measures
imed  at  comparing  the  unidimensional  solution  with  the
romin  rotated  solution  in  three  factors.  Clearly,  the  rotated
olution  univocally  demonstrates  added  value,  because  for
ll  three  factors,  the  true  factor  scores  are  better  pre-
icted  from  the  corresponding  estimates  than  from  the  score
stimates  in  the  single  general  factor  (results  in  brackets).
he  panel  also  displays  the  reliability  estimates  for  the  fac-
or  scores  derived  from  the  solutions,  as  well  as  the  alpha
stimates  for  the  raw  total  scale  scores.  The  ordinal  alpha
stimate  (Zumbo,  Gadermann,  &  Zeisser,  2007) has  been  also
ncluded  as  theoretical  upper  limit  for  the  reliability  of  the
otal  scores.
The  results  summarized  so  far,  suggest  that  the  best
olution  for  the  BSI-18  in  this  population  is  a  second-order
olution,  with  3  strongly  related  primary  factors  that  are
lear,  meaningful,  replicable,  and  lead  to  reliable  scores,  as
ell  as  a general  second-order  factor  that  runs  throughout
ll  the  items  and  that  can  be  understood  as  ‘‘psychological
istress.’’  This  general  factor  is  also  strong  and  replicable,
nd  provides  reliable  scores:  both  factor  score  estimates
nd  the  simpler  sum  scores  can  be  considered  to  be  reli-
ble  enough  to  be  used  in  clinical  assessment.  This  general
chema  leads  to  the  CFA  solutions  used  in  the  next  stage.
FAs  and  measurement  of  invariance
or  the  same  reasons  detailed  above,  and  also  for  consis-CFAs,  extended  validity  model,  and  two-wave  model)  used
he  same  UVA  strategy  as  the  EFA  models  in  the  previous
ection:  variables  were  treated  as  ordered-categorical,  and
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Table  3  Dimensional  assessment  using  exploratory  factor  analysis.
Panel  (a)  Fit  and  factor  dominance  results
Model  SRMRS  RMSEA  CFI  EVC  PA  BIC
1  factor  .086  .073  .981  .850  1  factor  (62.37%)  1002.05
3 factors  .034  .032  .997  --  --  679.18
Panel (b)  Added-value  and  quality  of  the  solutions  results
Added-value  H-
index/marginal
reliabil-
ity(EAP
scores)
Alpha
reliability
(raw  scores)
Ordinal  alpha
General  factor  –  .955  .90  .93
Depression  factor  .925  (.487)  .919
Anxiety  factor  .952  (.572)  .952
Somatization  factor  .847  (.278)  .850
Note: SMRS = Standardized Root Mean Squared Residual; RMSEA = Root Mean Square Error of Approximation; CFI = Comparative Fit Index;
ECV = Explained common variance; PA: Parallel Analysis; BIC: Bayesian Information Criterion; Added-Value results = ﬁrst value: mean
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obust  statistics  based  on  mean-and-variance  corrections
ere  used  for  assessing  model-data  ﬁt.
Based  on  the  EFA  results  in  the  previous  section,  a  second-
rder  CFA  model  with  three  primary  factors  was  ﬁtted  by
sing  again  a  cross-validation  schema  based  on  indepen-
ent  random  samples.  Across-sample  results  of  the  proposed
odel  were  virtually  the  same  in  terms  of  both,  parameter
stimates,  and  goodness-of-ﬁt  measures.  So,  it  is  justiﬁed
o  consider  a  common  solution,  that,  in  principle,  holds
or  the  entire  sample.  The  second-order  loadings  estimated
n  the  full  sample  were:  Depression  =  .98;  Anxiety  =  .84;
omatic  =  .69.  Based  on  this  common  solution,  strong  invari-
nce  assessments  were  next  carried  out.  Table  4  shows  the
trong  invariance  results  for  sex,  age,  and  tumor  location.  In
ll  cases,  the  strong-invariance  model  based  on  the  second-
rder  solution  has  a  remarkably  good  ﬁt  based  on  all  the
ndices  considered.
As  discussed  above,  if  measurement  invariance  is
chieved,  it  can  be  assumed  that  the  same  dimensions  are
easured  in  the  different  groups  and  that  the  items  function
n  the  same  way  in  these  groups.  Therefore,  differences  in
roup  mean  scores  can  be  validly  interpreted  as  reﬂecting
true’  group  differences  in  the  dimensions  being  measured.
o  as  to  interpret  the  mean  differences  in  Table  4, we  note
hat,  for  identiﬁcation  purposes,  the  means  are  always  ﬁxed
o  zero  in  the  ﬁrst  group  and  are  freely  estimated  in  the
emaining.  Results  can  be  summarized  as  follows:  no  mean
ifferences  in  any  of  the  primary  factors  were  obtained
or  tumor  location.  Finally,  and  as  regards  age  groups,  the
esults  clearly  suggest  that  the  levels  in  all  three  factors
end  to  decrease  with  age.onvergent  validity  and  assessment  of  change
alidity  results  in  Table  5  can  be  summarized  as  follows.
irst,  the  proﬁle  of  raw  validity  coefﬁcients  in  panel  (a)  and
f
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n
por, second value within brackets: mean squared error reduction
tandardized  coefﬁcients  in  panel  (b)  is  virtually  the  same,
hich  is  expected.  However,  the  disattenuated  standardized
oefﬁcients  are  higher  in  all  cases,  as  they  should  be,  and  the
ifferences  are  more  pronounced,  thereby  making  the  pat-
ern  in  (b)  more  easily  interpreted.  Second,  the  structural
odel  has  quite  an  acceptable  ﬁt.
As  for  the  substantive  results,  the  Depression  factor  is,
learly,  the  one  that  most  strongly  and  negatively  correlated
ith  the  MSPSS  scales.  Somatization  and  Anxiety  correlate
igniﬁcantly  in  all  cases,  albeit  effect  sizes  are  small.  Finally,
he  relations  revealed  with  respect  to  the  general  factor
ight  well  be  due  to  the  fact  that  it  mostly  reﬂects  depres-
ion.  Overall,  then,  less  perceived  social  support  appears
o  be  associated  with  all  BSI  factors,  but  especially  with
epression.
Table  6  presents  the  results  for  the  two-wave  longitu-
inal  model.  The  constraints  here  were  similar  to  those  in
he  previous  multiple-group  analyses  but  were  imposed  over
ime  instead  of  over  groups.  Thus,  strong  invariance  over
ime  was  assumed  and  the  mean  of  each  dimension  at  Time
 was  set  to  zero.  Results  can  be  summarized  as  follows.
irst,  the  models  exhibited  fairly  acceptable.  Second,  signif-
cant  pre-test  post-test  changes  were  observed  for  the  three
imensions:  a  mean  increase  in  Depression  and  Somatiza-
ion  and  a  mean  decrease  in  anxiety.  In  terms  of  effect  sizes
Cohen’s  d),  the  Depression  and  Anxiety  effects  would  be
ualiﬁed  as  small,  whereas  the  somatization  effect  is  more
ubstantial  and  would  qualify  as  medium.
iscussion
he  present  study  examines  the  BSI-18’s  (Derogatis,  2001)
actorial  structure,  invariance,  and  sensitivity  to  pre-/post-
reatment  change  in  a sample  of  adults  with  resected,
on-metastatic  cancer.  The  second-order  model  with  three
rimary  factors  that  ﬁt  the  original  proposed  structure  was
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Table  4  Results  of  the  strong  invariance  model  for  sex,  age,  and  tumor  site.
Groups  Means   2 (df)  CFI  RMSEA  (90%  CI)
DEP  ANX  SOM
Sex  513.12  (258)  .983  .047  (.041;  .053)
Men (ﬁxed)  0.00  0.00  0.00
Women  0.23*  0.47*  0.21*
Age group  (years)  509.89  (320)  .987  .045  (.038;  .052)
Group 1  (≤  55)  (ﬁxed)  0.00  0.00  0.00
Group  2  (55-65) -0.14  -0.26*  -0.20*
Group  3  (>65) -0.44*  -0.53*  -0.28*
Tumor 647.23  (413) .987  .044  (.037;  .050)
Colon (ﬁxed)  .00  .00  .00
Breast  .06  -.06  -.10
Others  .18  .13  .01
Note: SD = Standard Deviation; CFI = Comparative Fit Index; SMRS = Standardized Root Mean Squared Residual; RMSEA = Root Mean Square
Error of Approximation; * = signiﬁcantly different from zero at the .05 level (two-tailed).
Table  5  Validity  assessment.
(a)  Correlations  between  BSI-18  raw  scores  and  MSPSS
Scale  scores  Family  Friends  Signiﬁcant  others  MSPSS  total
Depression  -.23**  -.18**  -.20**  -.26**
Anxiety -.15**  -.09**  -.10**  -.14**
Somatization  -.12**  -.11**  -.13**  -.15**
General BSI -.19**  -.13**  -.17**  -.21**
*p <  .01;  **p  <  .001;  MPSS,  multidimensional  scale  of  perceived  social  support.
(b) Structural  standardized  validity  coefﬁcients  between  the  BSI-18  factors  and  MSPSS
Factor  Family  Friends  Signiﬁcant  others  MSPSS  total
Depression  -.31**  -.26**  -.28**  -.36**
Anxiety -.15**  -.11**  -.10**  -.15**
Somatization  -.14**  -.13**  -.15**  -.18**
General BSI  -.25**  -.19**  -.20**  -.27**
*p <  .01;  **p  <  .001;  MPSS,  multidimensional  scale  of  perceived  social  support.
(c) Goodness-of-ﬁt  results  for  the  structural  validity  model
2 (df)  CFI  RMSEA  (90%  CI)
539.62  (190)  .978  .046  (.041;  .051)
Table  6  Results  of  the  two-wave  model  for  assessing  change.
Means  2 (df)  CFI  RMSEA  (90%  CI)
Dimension  Time  1  Time  2  1095.37  (643)  .973  .037  (.033;  .040)
Depression 0.00  0.14*
Anxiety  0.00  -0.13*
Somatization  0.00  0.51*
Note: SD = Standard Deviation; CFI = Comparative Fit Index; RMSEA = Root Mean Square Error of Approximation; * = signiﬁcantly different
from zero at the .05 level (two-tailed).
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he  one  that  best  ﬁt  the  data  in  this  study.  The  invariance
tudy  indicates  that  the  BSI-18  was  equivalent  for  both  men
nd  women,  age,  and  tumor  site.  The  longitudinal  study
esults  demonstrate  that  the  scale  was  sensitive  to  the
hange.
Our  results  reveal  that  the  BSI-18’s  second-order  model
ith  three  primary  factors  (Depression,  Anxiety  and  Soma-
ization)  and  its  unifactorial  model  display  good  ﬁt  to  the
ata.  In  line  with  the  results  achieved  by  the  original  author
Derogatis,  2001)  and  in  various  studies  with  individuals
ith  cancer  (Galdón  et  al.,  2008;  Recklitis  et  al.,  2017),
ur  results  suggest  that  the  individual  subscales  offer  use-
ul  information  for  the  clinician  in  this  population  and  the
SI-18’s  single  dimension  can  contribute  to  evaluating  psy-
hological  distress  in  general.
In  addition,  this  study  also  analyzed  the  scale’s  invari-
nce  on  the  basis  of  sex,  age,  and  tumor  location,  using
ulti-group  CFA  models.  The  results  demonstrate  that  there
s  no  differential  functioning  of  the  BSI-18  items  according
o  sex  and,  therefore,  the  test’s  structure  is  equivalent  in
oth  men  and  women.  These  results  are  similar  to  those
eported  by  several  groups  (Li  et  al.,  2018;  Torres  et  al.,
013).  The  results  suggest  that  both  males  and  females  with
ancer  share  a  common  understanding  of  the  psychologi-
al  distress  evaluated  by  the  BSI-18,  despite  the  differences
ound  in  our  study  in  that  the  women  with  cancer  in  our
ample  report  higher  levels  of  Depression,  Anxiety,  and  Som-
tization  than  the  men,  similar  to  those  detected  in  earlier
tudies  (Chao  et  al.,  2019;  Jimenez-Fonseca  et  al.,  2018).
Most  items  were  also  interpreted  equivalently  across
umor-site  and  age-deﬁned  groups.  This  is  the  ﬁrst  study
o  examine  invariance  based  on  tumor  site  and  age.  No  dif-
erences  were  found  in  the  means  of  any  of  the  primary
actors  for  tumor  location,  although  the  same  cannot  be
aid  of  age.  The  results  indicate  that  the  levels  on  all  three
actors  tend  to  decrease  with  age.  Several  factors  might
ccount  for  these  differences.  Older  patients  have  more
riends  and/or  relatives  that  have  gone  through  the  same  sit-
ation;  consequently,  there  is  less  uncertainty.  This  patient
roup  also  tends  to  have  fewer  work  and/or  family  respon-
ibilities,  which  increase  the  stress  derived  from  what  they
re  experiencing.
The  internal,  single-wave  results  discussed  so  far,  sug-
ests  that  the  BSI-18  can  be  a  very  useful  instrument
or  clinical  assessment  in  the  population  of  interest.  The
nvariance  results  suggest  that  the  BSI-18  scores  mea-
ure  the  same  dimensions  and  with  the  same  scale  in  the
ub-groups  considered,  which  implies  that  the  trait  esti-
ates  of  individuals  are  comparable  regardless  of  their
ex,  age,  or  type  of  tumor.  Furthermore,  the  scores  are
ot  only  invariant,  but  highly  reliable  also,  which  implies
hat  accurate  measurements  can  be  made  at  the  individual
evel.
As  for  construct  validity,  the  Depression  factor  was  the
trongest  and  correlated  negatively  with  social  support.  Anx-
ety  and  Somatization  were  also  negatively  associated  with
ocial  support,  albeit  with  a  smaller  effect  size.  Studies  in
he  ﬁeld  of  health  have  found  that  social  support  is  an  impor-
ant  indicator  of  an  individual’s  mental  health  status  (Bao
t  al.,  2019;  Hill  &  Hamm,  2019).  In  our  sample,  Depres-
ion  was  the  dimension  that  exhibited  the  strongest  negative
orrelations;  in  keeping  with  earlier  studies,  our  results  also
1
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uggest  that  low  levels  of  social  support  can  aggravate  symp-
oms  of  depression  in  oncological  patients  (Bao  et  al.,  2019).
The  results  for  the  two-wave  longitudinal  model  shed
ight  on  the  change  at  six  months  on  the  three  factors  of
he  BSI-18  in  cancer  patients  after  receiving  chemotherapy.
ur  results  indicate  that  there  was  increased  in  Depres-
ion  and  Somatization  and  slight  decrease  in  anxiety  at  6
onths  post-treatment.  This  might  be  attributable  to  the
ffects  of  the  chemotherapy  administered  and  a  variety  of
ide  effects  it  may  have  caused,  such  as  nausea,  vomiting,
ain,  hair  loss,  fatigue,  etc.,  that  can  impact  patients’  low
ood  and  increase  physical  symptoms.  In  contrast,  Anxiety
as  slightly  lower  following  treatment  versus  at  the  begin-
ing.  Several  different  reasons  can  account  for  this:  when
nitiating  treatment,  patients  confront  a  life-threatening
edical  situation;  they  must  get  accustomed  to  the  hospi-
al  setting  and  frequent  testing  and  doctors’  visits;  there  is
ncertainty  between  one  test  and  the  next  or  between  treat-
ent  cycles  that  cause  them  to  be  more  vigilant.  With  time
nd  as  the  person  grows  accustomed  to  this  atmosphere  and
any  doubts  surrounding  treatment  and  its  repercussions
re  cleared  up,  anxiety  may  abate  somewhat.
This  study  has  a  series  of  limitations.  First,  the  sam-
le  is  heterogenous,  to  enable  tumor  site-based  subgroup
nalyses  to  be  conducted.  Second,  the  results  of  our  study
ight  not  necessarily  be  extrapolated  to  individuals  with
dvanced  tumors,  whose  clinical  status  and  prognosis  differ
arkedly.  Finally,  we  must  be  cautious  when  interpreting
hese  results,  bearing  in  mind  that  all  the  subjects  eligible
o  participate  did  so  voluntarily,  which  may  have  introduced
 self-selection  bias.  Likewise,  a  clinically  relevant  limita-
ion  is  the  absence  of  appropriately  matched  comparison
amples  to  assess  psychological  status.
The  strengths  of  this  study  include  its  prospective  design,
he  application  of  widely  validated  and  reliable  measures,
s  well  as  a  large  sample  of  oncological  patients  with  non-
dvanced,  resected  cancer  from  hospitals  all  over  Spain.
unding
his  work  was  funded  by  the  Spanish  Society  of  Medical
ncology  (SEOM)  in  2015.
ppendix 1. Brief Symptom Inventory-18
elow  is  a  list  of  problems  people  sometimes  have.  Read
ach  one  carefully  and  indicate  the  number  that  best
escribes  how  much  that  problem  has  distressed  or  bothered
ou  during  the  past  7  days  including  today.
1  Faintness  or  dizziness
2 Feeling  no  interest  in  things
3  Nervousness  or  shakiness  inside
4  Pains  in  heart  or  chest
5  Feeling  lonely
6  Feeling  tense  or  keyed  up
7  Nausea  or  upset  stomach
8  Feeling  blue
9  Suddenly  scared  for  no  reason
0  Trouble  getting  your  breath
1  Feelings  of  worthlessness
ympt
H
H
J
K
L
L
L
L
M
M
M
R
R
S
SFactor  structure  and  measurement  invariance  of  the  Brief  S
12  Spells  of  terror  or  panic
13  Numbness  or  tingling  in  parts  of  your  body
14  Feeling  hopeless  about  the  future
15  Feeling  so  restless  you  couldn’t  sit  still
16  Feeling  weak  in  parts  of  your  body
17  Thoughts  of  ending  your  life
18  Feeling  fearful
The  format  of  a  ﬁve-point  Likert  scale  from  0  (not  at  all)
to  4  (extremely).
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